Tag: Lung Cancer
Intas launches HETRONIFLY, India’s first immunotherapy for advanced small cell lung...
Serplulimab is the first PD-1 inhibitor worldwide to receive approval for ES-SCLC, and is currently present in over 40 countries
Pfizer’s LORBRENA achieves 60% five-year survival in ALK-positive lung cancer
Phase 3 CROWN trial shows 81% reduction in progression risk and 94% fewer brain metastases compared to XALKORI®
Major milestone met in AI-powered fight against lung cancer
Global initiative gains significant ground in digitally identifying cancer risk before symptoms even start
PCR Panels redefining the landscape of lung cancer testing globally
Due to the rising incidence and prevalence of lung cancer worldwide, the market for lung cancer PCR panels is expanding
AstraZeneca India partners with RGCI&RC to set up CoE to advance...
The centre will focus on the availability of subsidized, high-quality, NGS testing in eligible lung cancer patients